Peter Vuylsteke

7.3k citations
101 papers · 1.7k indexed · 1 hit paper · h-index 19
Topics
Ovarian cancer diagnosis and treatment (18 papers)HER2/EGFR in Cancer Research (17 papers)Breast Cancer Treatment Studies (15 papers)
Journals
The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Peter Vuylsteke

91 papers receiving 1.7k citations

Hit Papers

Olaparib combined with chemotherapy for recurrent platinu...20142026201820222014100200300400

Peers

Peter Vuylsteke
Comparison fields: 5 of 91
  • Oncology 1.1k
  • Molecular Biology 439
  • Pulmonary and Respiratory Medicine 411
  • Cancer Research 383
  • Reproductive Medicine 366
Replace Véronique D’Hondt with:
Véronique D’Hondt France
Ora Rosengarten Israel
Anthony Kong United Kingdom
Sharadah Essapen United Kingdom
Kathryn P. Gray United States
Marta Gil-Martín Spain
Susan Schumer United States
Nilsa C. Ramirez United States
Hideo Niibe Japan
He Huang China
Peter Vuylsteke relative to Véronique D’Hondt France Véronique D’Hondt's profile →
Citations per field
00.5×5.2×
Véronique D’Hondt · 1×
Citations per year

Countries citing papers authored by Peter Vuylsteke

Since Specialization
Citations

This map shows the geographic impact of Peter Vuylsteke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vuylsteke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vuylsteke more than expected).

Fields of papers citing papers by Peter Vuylsteke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vuylsteke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vuylsteke. The network helps show where Peter Vuylsteke may publish in the future.

Co-authorship network of co-authors of Peter Vuylsteke

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vuylsteke. A scholar is included among the top collaborators of Peter Vuylsteke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vuylsteke. Peter Vuylsteke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 12
5 4
6 55
7 1
8 0
9 8
10 5
11 14
12 2
13 81
14 20
15 16
16 56
17 2
18 45
19
First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicentre academic phase II study in caucasian patients (pts) (NCT00339586)
1
20 39

About Peter Vuylsteke

Peter Vuylsteke is a scholar working on Oncology, Reproductive Medicine and Cancer Research, having authored 101 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (18 papers), HER2/EGFR in Cancer Research (17 papers) and Breast Cancer Treatment Studies (15 papers). The work is most often cited by research in Reproductive Medicine (366 citations), Oncology (1.1k citations) and Cancer Research (383 citations). Peter Vuylsteke has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Gabe S. Sonke, Christopher Poole, Michael Friedländer, Helen Mackay, Nicoletta Colombo, David Cibula, Amit M. Oza, Ron H.J. Mathijssen, Jiří Špaček and Jacqui Rowbottom. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026